Original
Validación psicométrica de las escalas OAB-V8 y OAB-V3 para la detección de pacientes con probable vejiga hiperactiva en la población española
Psychometric validation of the OAB-V8 and OAB-V3 scales for the screening of patients with probable overactive bladder in the Spanish population
Francisco J. Brenesa,
, Javier C. Angulob, David Ochaytac, Javier Rejasd, Daniel Arumíe, Ana Cañadasf, Isabel Lizarragaf
Autor para correspondencia
a Centro de Atención Primaria Llefià, Badalona, Barcelona, España
b Servicio de Urología, Hospital Universitario de Getafe, Fundación para la Investigación Biomédica, Universidad Europea de Madrid, Getafe, Madrid, España
c Investigación de Resultados de Salud y Dossier de Valor, oYs Integra, Madrid, España
d Departamento de Farmacoeconomía e Investigación de Resultados de Salud, Pfizer S.L.U., Alcobendas, Madrid, España
e Unidad Médica, Pfizer Inc, Alcobendas, Madrid, España
f Unidad Médica, Pfizer, S.L.U., Alcobendas, Madrid, España
Leído
3872
Vecesse ha leído el artículo
3422
Total PDF
450
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 42 | 39 | 81 |
| 2025 11 | 0 | 34 | 34 |
| 2025 10 | 0 | 31 | 31 |
| 2025 9 | 0 | 16 | 16 |
| 2025 8 | 0 | 34 | 34 |
| 2025 7 | 0 | 5 | 5 |
| 2025 6 | 0 | 11 | 11 |
| 2025 5 | 0 | 22 | 22 |
| 2025 4 | 0 | 30 | 30 |
| 2025 3 | 0 | 11 | 11 |
| 2025 2 | 0 | 16 | 16 |
| 2025 1 | 0 | 16 | 16 |
| 2024 12 | 0 | 19 | 19 |
| 2024 11 | 0 | 12 | 12 |
| 2024 10 | 0 | 50 | 50 |
| 2024 9 | 0 | 24 | 24 |
| 2024 8 | 0 | 26 | 26 |
| 2024 7 | 0 | 43 | 43 |
| 2024 6 | 0 | 56 | 56 |
| 2024 5 | 0 | 76 | 76 |
| 2024 4 | 0 | 66 | 66 |
| 2024 3 | 0 | 43 | 43 |
| 2024 2 | 0 | 78 | 78 |
| 2024 1 | 0 | 51 | 51 |
| 2023 12 | 0 | 112 | 112 |
| 2023 11 | 0 | 112 | 112 |
| 2023 10 | 0 | 76 | 76 |
| 2023 9 | 0 | 41 | 41 |
| 2023 8 | 0 | 50 | 50 |
| 2023 7 | 0 | 135 | 135 |
| 2023 6 | 0 | 79 | 79 |
| 2023 5 | 0 | 57 | 57 |
| 2023 4 | 0 | 61 | 61 |
| 2023 3 | 20 | 49 | 69 |
| 2023 2 | 0 | 41 | 41 |
| 2022 1 | 0 | 52 | 52 |
| 2022 12 | 0 | 29 | 29 |
| 2022 11 | 0 | 61 | 61 |
| 2022 10 | 0 | 35 | 35 |
| 2022 9 | 0 | 39 | 39 |
| 2022 8 | 0 | 48 | 48 |
| 2022 7 | 0 | 23 | 23 |
| 2022 6 | 0 | 47 | 47 |
| 2022 5 | 0 | 42 | 42 |
| 2022 4 | 0 | 34 | 34 |
| 2022 3 | 0 | 51 | 51 |
| 2022 2 | 0 | 29 | 29 |
| 2021 1 | 0 | 47 | 47 |
| 2021 12 | 0 | 12 | 12 |
| 2021 11 | 0 | 27 | 27 |
| 2021 10 | 0 | 62 | 62 |
| 2021 9 | 0 | 34 | 34 |
| 2021 8 | 0 | 40 | 40 |
| 2021 7 | 0 | 31 | 31 |
| 2021 6 | 0 | 20 | 20 |
| 2021 5 | 0 | 42 | 42 |
| 2021 4 | 0 | 33 | 33 |
| 2021 3 | 0 | 30 | 30 |
| 2021 2 | 0 | 33 | 33 |
| 2020 1 | 0 | 32 | 32 |
| 2020 12 | 0 | 36 | 36 |
| 2020 11 | 0 | 28 | 28 |
| 2020 10 | 0 | 29 | 29 |
| 2020 9 | 0 | 21 | 21 |
| 2020 8 | 0 | 43 | 43 |
| 2020 7 | 0 | 12 | 12 |
| 2020 6 | 0 | 18 | 18 |
| 2020 5 | 0 | 30 | 30 |
| 2020 4 | 0 | 31 | 31 |
| 2020 3 | 0 | 20 | 20 |
| 2020 2 | 0 | 17 | 17 |
| 2020 1 | 0 | 29 | 29 |
| 2019 12 | 0 | 40 | 40 |
| 2019 11 | 0 | 23 | 23 |
| 2019 10 | 0 | 24 | 24 |
| 2019 9 | 0 | 13 | 13 |
| 2019 8 | 0 | 3 | 3 |
| 2019 7 | 0 | 24 | 24 |
| 2019 6 | 0 | 37 | 37 |
| 2019 5 | 0 | 120 | 120 |
| 2019 4 | 0 | 76 | 76 |
| 2019 3 | 0 | 6 | 6 |
| 2019 2 | 0 | 20 | 20 |
| 2019 1 | 0 | 8 | 8 |
| 2018 12 | 0 | 23 | 23 |
| 2018 11 | 0 | 17 | 17 |
| 2018 10 | 0 | 30 | 30 |
| 2017 12 | 1 | 0 | 1 |
| 2017 11 | 1 | 1 | 2 |
| 2017 10 | 21 | 2 | 23 |
| 2017 9 | 50 | 10 | 60 |
| 2017 8 | 33 | 2 | 35 |
| 2017 7 | 42 | 10 | 52 |
| 2017 6 | 39 | 10 | 49 |
| 2017 5 | 50 | 8 | 58 |
| 2017 4 | 36 | 7 | 43 |
| 2017 3 | 33 | 21 | 54 |
| 2017 2 | 26 | 5 | 31 |
| 2016 1 | 27 | 4 | 31 |
| 2016 12 | 18 | 1 | 19 |
| 2016 11 | 0 | 1 | 1 |
| 2016 9 | 1 | 1 | 2 |
| 2016 5 | 0 | 1 | 1 |
| 2015 4 | 1 | 1 | 2 |
| 2015 1 | 1 | 1 | 2 |
| 2014 12 | 7 | 3 | 10 |
| 2014 11 | 1 | 0 | 1 |
Mostrar todo
